The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
Document Type
Journal Article
Publication Date
4-25-2020
Journal
Journal of the American Academy of Dermatology
DOI
10.1016/j.jaad.2020.04.104
APA Citation
Simpson, E., Bissonnette, R., Eichenfield, L., Guttman-Yassky, E., King, B., Silverberg, J. I., Beck, L., Bieber, T., Reich, K., Kabashima, K., Seyger, M., Siegfried, E., Stingl, G., Feldman, S., Menter, A., van de Kerkhof, P., Yosipovitch, G., Paul, C., Martel, P., Dubost-Brama, A., Armstrong, J., Chavda, R., Frey, S., Joubert, Y., Milutinovic, M., Parneix, A., Teixeira, H., Lin, C., Sun, L., Klekotka, P., Nickoloff, B., Dutronc, Y., Mallbris, L., Janes, J., DeLozier, A., Nunes, F., & Paller, A. (2020). The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.. Journal of the American Academy of Dermatology, (). http://dx.doi.org/10.1016/j.jaad.2020.04.104
Peer Reviewed
1
Comments
Online ahead of print